Cysteinyl leukotrienes in asthma: old mediators up to new tricks

Douglas W.P. Hay, Theodore J. Torphy, Bradley J. Undem

Research output: Contribution to journalReview articlepeer-review

168 Scopus citations


The cysteinyl leukotrienes have long been suspected to play a role in the pathogenesis of asthma. This speculation was based largely on their release in human lung following antigen challenge as well as their potent bronchoconstrictor activity. However, there is increasing evidence that the cysteinyl leukotrienes also produce several pro-inflammatory effects and alter the activity of neuronal pathways in the airways. Douglas Hay, Theodore Torphy and Bradley Undem review these recent data and discuss the therapeutic possibilities of cysteinyl leukotriene receptor antagonists and 5-lipoxygenase inhibitors.

Original languageEnglish (US)
Pages (from-to)304-309
Number of pages6
JournalTrends in Pharmacological Sciences
Issue number9
StatePublished - Sep 1995

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology


Dive into the research topics of 'Cysteinyl leukotrienes in asthma: old mediators up to new tricks'. Together they form a unique fingerprint.

Cite this